四氧化三钴-聚乙二醇-三苯基膦纳米颗粒通过诱导BNIP3介导的线粒体自噬改善急性至慢性肾脏病转化
研究合成四氧化三钴-聚乙二醇-三苯基膦(COPT)纳米颗粒,在小鼠缺血性AKI和斑马鱼庆大霉素诱导AKI模型中验证其肾脏近端小管蓄积并减轻损伤、抑制AKI向CKD转化,机制为剂量依赖性诱导BNIP3表达增强线粒体自噬。
要点
- COPT纳米颗粒优先蓄积于肾脏近端小管细胞并减轻小鼠缺血性AKI和斑马鱼庆大霉素诱导AKI。
- COPT抑制AKI向CKD转化且副作用少。
- COPT通过剂量依赖性诱导BNIP3表达增强线粒体自噬保护线粒体,BNIP3敲低削弱该效应。
核心结论
- COPT纳米颗粒通过诱导BNIP3介导的线粒体自噬改善AKI及其向CKD进展,提示COPT可能作为有前景的线粒体靶向AKI治疗剂。
研究设计与样本
- 本研究合成并鉴定四氧化三钴-聚乙二醇-三苯基膦(COPT)纳米颗粒,在小鼠缺血性AKI模型、斑马鱼庆大霉素诱导AKI模型及体外实验中评价其作用与机制。
主要发现
- COPT优先蓄积于肾脏近端小管细胞,并显著减轻小鼠缺血性AKI和斑马鱼庆大霉素诱导的AKI。
- COPT抑制AKI向CKD转化,且副作用少。
- COPT定位于线粒体,在体内外通过增强线粒体自噬改善缺氧-复氧介导的线粒体损伤。
- COPT剂量依赖性诱导BNIP3表达,而BNIP3敲低减弱COPT诱导的线粒体自噬流和线粒体保护作用。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accumulating evidence highlights mitochondrial dysfunction as a crucial factor in the pathogenesis of acute kidney injury (AKI); thus, novel therapeutic strategies maintaining mitochondrial homeostasis are highly anticipated. Recent studies have shown that cobaltosic oxide has peroxidase-like catalytic activities, although its role and mechanism remain elusive in AKI. In the present study, we synthesized and identified cobaltosic oxide-polyethylene glycol-triphenylphosphine (COPT) nanoparticles by conjugating cobaltosic oxide with polyethylene glycol and triphenylphosphine, to improve its biocompatibility and mitochondria-targeting property. We found that COPT preferentially accumulated in the kidney proximal tubule cells, and significantly alleviated ischemic AKI in mouse models and gentamicin induced-AKI in the zebrafish model. COPT also inhibited the transition from AKI to chronic kidney disease (CKD), with few side effects. Further studies demonstrated that COPT localized in the mitochondria, and ameliorated hypoxia-reoxygenation-mediated mitochondrial damage through enhancing mitophagy in vitro and in vivo. Mechanistically, COPT dose-dependently induced the expression of Bcl-2/adenovirus E1B 19-kDa interacting protein (BNIP3), while knockdown of BNIP3 attenuated COPT-induced mitophagic flux and mitochondrial protection. Thus, our findings suggest that COPT nanoparticles ameliorate AKI and its progression to CKD through inducing BNIP3-mediated mitophagy, indicating that COPT may serve as a promising mitochondria-targeting therapeutic agent against AKI.
引用
- Qin S, Liu C, Chen Y, et al. Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy. Kidney Int. 2023. PMID: 36805450. doi:10.1016/j.kint.2023.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。